Chemours enhances board with former Hershey executive

WILMINGTON, Del. - The Chemours Company (NYSE: NYSE:CC), a global chemistry company with leading positions in several markets and currently valued at $2.7 billion, announced the appointment of Leslie M. Turner, a former executive at Hershey and Coca-Cola, to its Board of Directors, effective February 19, 2025. According to InvestingPro data, the company maintains a Fair Value in line with its current market price, while offering a notable 5.6% dividend yield. The addition of Turner is expected to bring a wealth of legal, governance, and policy expertise to the board, complementing the company’s strategic direction.

Turner’s career includes a notable history of advising corporate boards, executives, and government leaders on complex legal and regulatory matters. Her experience spans various roles, including serving as Senior Vice President, General Counsel, and Corporate Secretary at The Hershey Company (NYSE:HSY), where she oversaw legal, government relations, and corporate security functions. Prior to her tenure at Hershey, Turner held significant positions at the Coca-Cola Company (NYSE:KO) and within the U.S. Department of the Interior. Her appointment comes as Chemours faces financial challenges, with InvestingPro analysis showing a significant debt burden and a debt-to-equity ratio of 6.5x.

Dawn Farrell, the Board Chair of Chemours, highlighted Turner’s proven track record and the diverse skills she brings to the board, which are seen as invaluable to the company’s future growth and shareholder value creation.

Turner also has a strong educational background with degrees from New York University and Georgetown University Law Center, as well as a Master of Laws from American University’s Washington College of Law. Additionally, she serves on the Board of Directors for FirstEnergy Corporation (NYSE:FE) and is actively involved with several non-profit organizations.

In related news, Chemours has confirmed that its 2025 Annual Shareholders Meeting will be held on April 22, 2025, marking a return to its regular annual meeting schedule. Investors following the company’s performance can access comprehensive analysis through InvestingPro, which offers detailed insights into Chemours’ financial health score of 2.13 (rated as ’FAIR’) and reveals 8 additional exclusive ProTips about the company’s performance.

Chemours, headquartered in Wilmington, Delaware, operates across various sectors, including coatings, plastics, refrigeration, and air conditioning, among others. The company is known for its prominent brands such as Opteon™, Freon™, and Teflon™, and has a workforce of approximately 6,100 employees serving around 2,700 customers in nearly 110 countries. The company generated revenues of $5.7 billion in the last twelve months, with analysts expecting improved profitability in the coming year despite current market volatility, as indicated by its beta of 1.8.

The information in this article is based on a press release statement from Chemours.

In other recent news, Chemours has seen a flurry of developments. Truist Securities upgraded Chemours’ stock rating to Buy and set a $27 price target, citing expected earnings growth in the years 2025-26, largely due to the potential of the company’s next-generation refrigerant Opteon franchise and the anticipated earnings recovery in the Titanium Dioxide (TiO2) segment. Furthermore, the company announced the appointment of Damián Gumpel as the President of its Titanium Technologies business segment, a move that is expected to bolster this area of the company.

In addition, Chemours has welcomed Joseph Kava, known for leading Google (NASDAQ:GOOGL)’s Data Center Business, to its Board of Directors. BMO Capital Markets maintained a positive outlook on the company following this strategic appointment, reiterating its Outperform rating and $34.00 price target. Kava’s expertise is anticipated to be instrumental in guiding Chemours’ two-phase immersion cooling (2PIC) platform.

Lastly, Chemours and The PCC Group announced plans to construct a new chlor-alkali facility in DeLisle, Mississippi, at Chemours’ existing TiO2 site. This facility, expected to start construction in 2026, will have a capacity of 340 kilotons, representing roughly 2% of North America’s total capacity. Despite potential future headwinds from the new facility’s operation, KeyBanc Capital Markets maintained its Overweight rating on Olin (NYSE:OLN) Corporation, the primary chlorine supplier to Chemours’ DeLisle facility.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.